glp-1 euglycemic dka Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights GLP-1 mimetics and diabetic ketoacidosis:
Description
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.
Its also known to reduce the risk of major cardiovascular events, []
Looking Ahead As the market evolves, stakeholders are watching for regulatory updates and court decisions that could reshape the boundaries of compounding
Meanwhile, Eli Lilly is advancing orforglipron, the first small-molecule GLP-1 receptor agonist for obesity
Reduces cravings & appetite*
Amazon is stepping into the GLP-1 arena, with the consumer giant positioning itself as a competitor to Hims & Hers Health
